Clinical Trials Browser

Phase 2 × Homoharringtonine × Other hematologic neoplasm × Clear all

NCT07507825 2026-04-02

VHAG

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07505160 2026-04-01

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06483906 2026-03-03

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05906914 2026-02-04

CHA

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04126681 2025-03-03

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT06742463 2024-12-19

VHAG in Treating R/R T-ALL/LBL

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06221683 2024-08-22

GMCAII

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04248595 2022-09-08

Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00462943 2021-12-28

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Phase 2 Completed

100 enrolled 25 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00375219 2021-11-15

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Phase 2 Completed

103 enrolled 24 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02159872 2021-06-09

Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure

Phase 2 Completed

48 enrolled 9 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes

NCT03135054 2020-12-10

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03170895 2020-03-30

Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01873495 2019-09-24

Omacetaxine for Consolidation and Maintenance

Phase 2 Terminated

7 enrolled 9 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01272245 2018-05-30

Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Phase 2 Completed

36 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT02029417 2016-05-09

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase 2 Terminated

2 enrolled 6 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00114959 2015-01-15

Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)

Phase 2 Terminated

15 enrolled 6 charts

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00003694 2013-06-05

Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00002574 2013-02-05

Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00006364 2013-01-23

Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00003239 2012-07-30

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase